✦ LIBER ✦

Screening for neuroblastoma

✍ Scribed by Alvin M. Mauer

Book ID: 119463021
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 192 KB
Volume: 112
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(88)80171-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ L. Parker 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Screening for neuroblastoma

✍ FreimutH. Schilling; Rudolf Erttmann; PeterF. Ambros; Sabine Strehl; Holger Chri 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 427 KB

Japanese mass screening for neuroblastom

Japanese mass screening for neuroblastoma

✍ Kei Kudo; Yumiko Arai; Yoshiaki Kondo 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 22 KB

Value of screening for neuroblastoma?

✍ Louise Parker 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 172 KB

Colloquy on Neuroblastoma Screening: Is

Colloquy on Neuroblastoma Screening: Is there a future for neuroblastoma mass screening?

✍ Bessho, Fumio 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

It is apparent that mass screening at the age of six months in Japan detects significant numbers of otherwise spontaneously regressing tumors. Nishi et al. estimated that at least 50% of tumors detected by screening with the HPLC method would otherwise regress spontaneously [31]. Considering that no

Mass screening for neuroblastoma in Japa

Mass screening for neuroblastoma in Japan

✍ Sawada, Tadashi; Nishi, Motoi; Takeda, Takeo; Iehara, Tomoko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Results of a 11-year-experience with mass screening for neuroblastoma in 6-month-old infants in Japan are presented. From 11,284,837 infants who were screened, 1,400 cases of neuroblastoma were detected, an incidence of 1/ 6,500-7,500 infants by HPLC screening. Most of the cases (75%) were at stages